Chemicals and Drugs

Panitumumab

Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

Synonyms

7 entry terms
  • ABX-EGF MAb
  • ABX-EGF Monoclonal Antibody
  • Panitumumab Antibody, Human
  • ABX EGF Monoclonal Antibody
  • Human Panitumumab Antibody
  • Monoclonal Antibody, ABX-EGF
  • Vectibix

MeSH Record

Aspects Covered

24 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2019 (2005)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Panitumumab. Medical Subject Headings (MeSH). 2026. Unique ID D000077544. http://id.nlm.nih.gov/mesh/2026/D000077544
  2. Panitumumab. In: Wikipedia. https://en.wikipedia.org/wiki/Panitumumab
  3. Panitumumab. In: Wikidata. https://www.wikidata.org/wiki/Q417775